OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
00849060

Suheung Co Ltd

Specialty ChemicalsVerified

Suheung Co Ltd maintains a debt-to-equity ratio of 0.89, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 1.27, suggesting it can cover its short-term obligations but with limited buffer. The company's cash and equivalents amount to 48,157,831,030 KRW, which is insufficient to cover its long-term debt of 435,080,435,510 KRW, resulting in a net cash deficit. In terms of profitability, Suheung Co Ltd reports a return on equity (ROE) of 8.9% and a return on assets (ROA) of 4.1%. These figures are below the industry median for Specialty Chemicals, which typically sees ROE and ROA in the 10-12% and 5-6% ranges, respectively. The company's operating margin is 6.85% (calculated from operating income of 49,496,950,450 KRW on revenue of 722,308,593,850 KRW), which is also below the industry median of 7.5%. The company's revenue is distributed across three segments: Capsule, Raw Material, and Cosmetics. The Capsule segment is the primary revenue driver, with the Raw Material and Cosmetics segments contributing to a lesser extent. Geographically, the company is heavily concentrated in South Korea, with no significant international revenue disclosed in the latest financials. Suheung Co Ltd's growth trajectory is modest, with analysts forecasting a mean revenue estimate of 767,500,000,000 KRW for the current fiscal year, representing a 6.3% increase from the last actual revenue of 722,308,590,000 KRW. The company's capital expenditure of -45,588,780,220 KRW indicates a reduction in investment, which may signal a focus on cost optimization rather than expansion. The company's risk profile is characterized by medium liquidity risk and low dilution risk. The key flag of net cash being negative after subtracting total debt highlights the company's leverage risk. However, the low dilution risk suggests that the company is not expected to issue additional shares in the near term, preserving shareholder value. Recent events include the publication of the latest financial snapshot, which provides updated figures for revenue, gross profit, and operating income. Analyst estimates for the upcoming fiscal year indicate a slight increase in revenue and earnings, but the company must manage its debt load to maintain financial stability.

30-day price · 008490+80.00 (+0.4%)
Low$17570.00High$21600.00Close$18740.00As of12 May, 00:00 UTC
Profile
CompanySuheung Co Ltd
Ticker008490.KS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Suheung Co Ltd is a Korea-based company primarily engaged in the capsule manufacturing business, operating through three segments: Capsule, Raw Material, and Cosmetics.

Classification. Suheung Co Ltd is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with a confidence level of 0.92.

Suheung Co Ltd maintains a debt-to-equity ratio of 0.89, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 1.27, suggesting it can cover its short-term obligations but with limited buffer. The company's cash and equivalents amount to 48,157,831,030 KRW, which is insufficient to cover its long-term debt of 435,080,435,510 KRW, resulting in a net cash deficit. In terms of profitability, Suheung Co Ltd reports a return on equity (ROE) of 8.9% and a return on assets (ROA) of 4.1%. These figures are below the industry median for Specialty Chemicals, which typically sees ROE and ROA in the 10-12% and 5-6% ranges, respectively. The company's operating margin is 6.85% (calculated from operating income of 49,496,950,450 KRW on revenue of 722,308,593,850 KRW), which is also below the industry median of 7.5%. The company's revenue is distributed across three segments: Capsule, Raw Material, and Cosmetics. The Capsule segment is the primary revenue driver, with the Raw Material and Cosmetics segments contributing to a lesser extent. Geographically, the company is heavily concentrated in South Korea, with no significant international revenue disclosed in the latest financials. Suheung Co Ltd's growth trajectory is modest, with analysts forecasting a mean revenue estimate of 767,500,000,000 KRW for the current fiscal year, representing a 6.3% increase from the last actual revenue of 722,308,590,000 KRW. The company's capital expenditure of -45,588,780,220 KRW indicates a reduction in investment, which may signal a focus on cost optimization rather than expansion. The company's risk profile is characterized by medium liquidity risk and low dilution risk. The key flag of net cash being negative after subtracting total debt highlights the company's leverage risk. However, the low dilution risk suggests that the company is not expected to issue additional shares in the near term, preserving shareholder value. Recent events include the publication of the latest financial snapshot, which provides updated figures for revenue, gross profit, and operating income. Analyst estimates for the upcoming fiscal year indicate a slight increase in revenue and earnings, but the company must manage its debt load to maintain financial stability.
Key takeaways
  • Suheung Co Ltd operates in the Specialty Chemicals industry with a focus on capsule manufacturing and related products.
  • The company's debt-to-equity ratio of 0.89 and current ratio of 1.27 indicate a moderate liquidity position.
  • ROE of 8.9% and ROA of 4.1% are below the industry median, suggesting room for improvement in profitability.
  • Revenue is concentrated in South Korea, with no significant international exposure disclosed.
  • Analysts forecast a modest 6.3% revenue growth for the current fiscal year.
  • The company faces leverage risk due to a net cash deficit after subtracting total debt.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$722.31B
Gross profit$129.46B
Operating income$49.50B
Net income$43.49B
R&D
SG&A
D&A
SBC
Operating cash flow$76.86B
CapEx-$45.59B
Free cash flow$34.71B
Total assets$1.06T
Total liabilities$572.46B
Total equity$488.68B
Cash & equivalents$48.16B
Long-term debt$435.08B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$722.31B$49.50B$43.49B$34.71B
FY-1$653.26B$33.25B$18.28B$20.59B
FY-2$594.57B$42.51B$6.12B-$9.82B
FY-3$634.97B$60.86B$33.98B$6.28B
FY-4$596.73B$67.46B$53.69B$51.92B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$1.06T$488.68B$48.16B
FY-1$1.02T$454.68B$37.93B
FY-2$993.74B$425.67B$38.71B
FY-3$926.42B$421.34B$37.02B
FY-4$809.95B$387.76B$26.33B
PeriodOCFCapExFCFSBC
FY0$76.86B-$45.59B$34.71B
FY-1$56.16B-$38.04B$20.59B
FY-2$10.49B-$50.56B-$9.82B
FY-3$52.91B-$64.18B$6.28B
FY-4$66.85B-$38.14B$51.92B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$166.40B$4.11B$4.64B-$652.9M
FQ-1$185.05B$13.71B$8.98B$9.17B
FQ-2$190.02B$20.12B$23.94B$19.99B
FQ-3$180.84B$11.55B$5.93B$6.21B
FQ-4$148.57B$2.77B$618.7M$2.70B
FQ-5$166.59B$7.43B$10.64B$8.92B
FQ-6$172.77B$10.90B$1.90B$3.32B
FQ-7$165.34B$12.14B$5.12B$5.66B
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$1.06T$488.68B$48.16B
FQ-1$1.03T$480.74B$63.29B
FQ-2$1.02T$469.75B$48.98B
FQ-3$1.01T$458.05B$39.49B
FQ-4$1.02T$454.68B$37.93B
FQ-5$999.72B$444.20B$39.34B
FQ-6$1.03T$437.23B$41.45B
FQ-7$1.01T$433.18B$39.63B
PeriodOCFCapExFCFSBC
FQ0$76.86B-$45.59B-$652.9M
FQ-1$67.57B-$28.37B$9.17B
FQ-2$43.18B-$17.30B$19.99B
FQ-3$23.08B-$5.77B$6.21B
FQ-4$56.16B-$38.04B$2.70B
FQ-5$43.06B-$28.73B$8.92B
FQ-6$33.32B-$17.04B$3.32B
FQ-7$15.73B-$8.60B$5.66B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$488.68B
Net cash-$386.92B
Current ratio1.3
Debt/Equity0.9
ROA4.1%
ROE8.9%
Cash conversion1.8%
CapEx/Revenue-6.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric008490Activity
Op margin6.9%0.4% medp25 -8.0% · p75 16.0%above median
Net margin6.0%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin17.9%20.8% medp25 14.9% · p75 24.0%below median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-6.3%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity89.0%59.0% medp25 54.9% · p75 72.9%top quartile
Observations
IR observations
Mean EPS estimate4,473.00 KRW
Last actual EPS3,911.00 KRW
Mean revenue estimate767,500,000,000 KRW
Last actual revenue722,308,590,000 KRW
Mean EBIT estimate67,300,000,000 KRW
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-15 22:55 UTC#af29585a
Source: analysis-pipeline (hybrid)Generated: 2026-05-15 22:57 UTCJob: 48f426ff